Loading...
Market
What will be AMD's market share in healthcare AI semiconductors by end of 2025?
2
Resolution / Starting Odds
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Market research reports or industry analysis publications
Story
AMD Invests $20M in AI-Driven Absci Structured as PIPE to Boost Drug Discovery Efforts
Jan 8, 2025, 11:50 AM
Advanced Micro Devices (AMD) has made a $20 million investment in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. This strategic investment, reported by the Wall Street Journal, is part of AMD's initiative to market its AI semiconductors to the healthcare sector. The investment is structured as a private investment in public equity (PIPE) and aims to assist Absci in reducing its hardware costs by migrating some of its workloads to AMD's technology. This move underscores AMD's commitment to expanding its presence in the healthcare industry through innovative AI applications.
View original story
Similar markets
10% to 20% • 25%
More than 30% • 25%
20% to 30% • 25%
Less than 10% • 25%
Minor Player (5-20%) • 25%
Niche Player (<5%) • 25%
Major Player (20-40%) • 25%
Leader (>40%) • 25%
Increased • 25%
Decreased • 25%
No change • 25%
Other • 25%
Nvidia loses significant market share • 25%
Nvidia faces strong competition but stays competitive • 25%
Nvidia remains the leader • 25%
Nvidia partners or merges with another major tech company • 25%
Below 10% • 25%
Above 30% • 25%
10%-20% • 25%
20%-30% • 25%
Exit market • 25%
No significant change • 25%
Decrease • 25%
Increase • 25%
Microsoft • 25%
Meta • 25%
TensorWave • 25%
Oracle • 25%
Above 20% • 25%
15% to 20% • 25%
10% to 15% • 25%
Below 10% • 25%
Yes • 50%
No • 50%
Less than 5% • 25%
More than 20% • 25%
10% to 20% • 25%
5% to 10% • 25%
